Below are the financial statements of BioMarin Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 |
|---|---|---|
| Current assets | — | — |
| Cash and cash equivalents | 942.84a | 755.13a |
| Short-term investments | 194.86a | 318.68a |
| Accounts receivable, net | 660.54a | 633.7a |
| Inventory | 1,232.65a | 1,107.18a |
| Other current assets | 201.53a | 141.39a |
| Total current assets | 3,232.43a | 2,956.09a |
| Noncurrent assets | — | — |
| Long-term investments | 521.24a | 611.14a |
| Property, plant and equipment, net | 1,043.04a | 1,066.13a |
| Intangible assets, net | 255.28a | 294.7a |
| Goodwill | 196.2a | 196.2a |
| Deferred tax assets | 1,489.37a | 1,545.81a |
| Other assets | 251.39a | 171.54a |
| Total assets | 6,988.94a | 6,841.6a |
| Current liabilities | — | — |
| Accounts payable and accrued liabilities | 606.99a | 683.15a |
| Short-term convertible debt, net | 0a | 493.88a |
| Total current liabilities | 606.99a | 1,177.02a |
| Noncurrent liabilities | — | — |
| Long-term convertible debt, net | 595.14a | 593.1a |
| Other long-term liabilities | 128.82a | 119.94a |
| Liabilities and stockholders’ equity | — | — |
| Total liabilities | 1,330.95a | 1,890.05a |
| Stockholders’ equity | — | — |
| Common stock | 0.19a | 0.19a |
| Additional paid-in capital | 5,802.07a | 5,611.56a |
| Company common stock held by the nonqualified deferred compensation plan | -11.23a | -9.86a |
| Accumulated other comprehensive income (loss) | 61.65a | -28.79a |
| Accumulated deficit | -194.7a | -621.55a |
| Total stockholders’ equity | 5,657.99a | 4,951.55a |
| Total liabilities and stockholders’ equity | 6,988.94a | 6,841.6a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BioMarin Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.